Semaglutide trials for Obesity

All Semaglutide trials · All Obesity trials

Phase breakdown

Recruiting trials studying Semaglutide for Obesity

• A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
  NCT07767175 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
  NCT07639021 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 25 locations
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 147 locations
• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
  NCT07253285 · Phase: Phase 3 · Ages: 8 Years to 18 Years · Sex: All (male and female) · 121 locations
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
  NCT07564414 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 303 locations
• A Study of BGM0504 in Early T2DM With Obesity
  NCT07743983 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)
  NCT07101939 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 7 locations
• Effect of Semaglutide in Patients With Psoriasis and Obesity
  NCT06937060 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.
  NCT07242534 · Phase: Phase 4 · Ages: 18 Years to 38 Years · Sex: Female · 5 locations
• Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies
  NCT07732426 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years to 50 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
  NCT06762314 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
  NCT07284979 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 59 locations
• Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
  NCT07225816 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity
  NCT07091500 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 75 Years · Sex: All (male and female) · 1 location
• Impact of Semaglutide on Tobacco Use and Related Health Behaviors
  NCT06986993 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
  NCT07213466 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
  NCT06396416 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Probiotic Intervention on Body Weight
  NCT06989177 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 50 Years · Sex: All (male and female) · 1 location
• Protein Supplementation Intervention on Body Weight
  NCT06989203 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 50 Years · Sex: All (male and female) · 1 location
• Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
  NCT07770841 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 62 locations
• Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity
  NCT07293325 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
  NCT06499857 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes
  NCT07317115 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Sit Less, Interact and Move More (SLIMM) 2 Study
  NCT05173714 · Phase: Phase 2 · Ages: 20 Years and older · Sex: All (male and female) · 4 locations
• Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
  NCT07621419 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
  NCT07010432 · Phase: Phase 1 · Ages: 50 Years to 70 Years · Sex: Female · 1 location
• Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
  NCT07527195 · Phase: Phase 1 · Ages: 50 Years to 70 Years · Sex: All (male and female) · 1 location
• Weight Loss in Adults Using Semaglutide (Real-world Study)
  NCT07627074 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials study Semaglutide for Obesity?

28 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.